INTRODUCTION {#sec1-1}
============

Cervical spinal stenosis (CSS) is defined as an abnormal narrowing of the cervical spinal canal.\[[@ref1]\] The essential clinical challenges with CSS are altered cervical spinal cord function and cervical radiculopathy. Narrowing of the cervical spinal canal may be unassociated with a separate pathologic process affecting the spinal cord or other portions of the nervous system.\[[@ref2]\] CSS can result from any process that narrows the canal. It can be congenital and usually produces no clinical disease in childhood. When degenerative conditions of the spine are superimposed on congenital stenosis, the adults may begin to show symptoms or signs of degenerative spine disease prematurely in the age of 30--40 years.\[[@ref3]\] The abnormal cord signal should be juxtaposed to the stenotic segment and not at a different cervical spine level in order to be postulated as related to the spinal stenosis. The prognosis of CSS depends on the function of the patient at the time of diagnosis and the underlying etiology.\[[@ref4][@ref5]\]

Usually, pulmonary function and respiratory muscles movement are under control of phrenic nerve (C3-C5), intercostal nerves (T2-T10), and sympathetic neurons (T1-L3). The diaphragm is the most important inspiratory muscle, accounting for 75% of the increase in lung volume during quiet inspiration; intercostal, scalene, and sternocleidomastoid muscles contribute the remaining 25%.\[[@ref6]\] There is little crossover innervation of the right and left hemidiaphragms, and each can contract independently of the other in the event of unilateral phrenic nerve palsy. In the presence of diaphragmatic paresis, inspiration is achieved largely by contraction of intercostal and accessory muscles and expansion of the rib cage.\[[@ref7]\]

Phrenic nerve palsy leading to hemidiaphragmatic paresis may be a temporary or persistent phenomenon after cervical cord injury and CSS. Transient phrenic nerve palsy appears to have little clinical significance in terms of both objective (respiratory support) and subjective (dyspnea) features. Persistent phrenic nerve palsy is common after acute cervical cord injury which may lead to acute pulmonary dysfunction.\[[@ref8]\]

Electrophysiologic studies have been conducted on patients with cervical cord stenosis, specifically addressing the phrenic nerve. Muscle action potentials (MAPs) from the diaphragm as an indirect assessment of spinal cord dysfunction. The phrenic nucleus resides in the ventral gray horn from C3 to C5 of the spinal cord. CMAP is elicited from transcranial electrical stimulation of the motor cortex in patients with high cervical myelopathy.\[[@ref9]\]

Therefore, the aim of the present study was to elucidate the potential effect of CSS on the pulmonary functions.

METHODS {#sec1-2}
=======

This is case--control, randomized, single-center study involved forty patients (30 females + 10 males) with cervical spine stenosis compared with sixty healthy individuals. The patients were recruited from the Consultant Unite of Department of Neurosurgery in cooperation with Department of Orthopedic of AL-Imamian AL-Kadhymiyian Medical City during the period from November 2018 to May 2019, Baghdad Iraq. The recruited patients were aged 25--70 years, body mass index (BMI) \<30 Kg/m^2^ with duration of their disease ranged 1--24 months. The study was approved by the Institutional Review Board of the College of Medicine, Al-Nahrain University, and informed consent was obtained from all the participants.

All patients were clinically examined and diagnosed by magnetic resonance imaging and other radiological diagnostic tools such as computing tomography scanning and X-ray of the cervical spine to determine the level of cervical cord compression. The diagnosis was supported by transcranial magnetic stimulation technique.

Inclusion criteria {#sec2-1}
------------------

Any patients with cervical canal stenosis with duration of 1--24 months with or without pulmonary dysfunctions were included in the study.

Exclusion criteria {#sec2-2}
------------------

Obesity, chronic smoking, obstructive airway diseases, restrictive airway diseases, malignancy, congenital spinal stenosis, peripheral neuropathy, diabetes mellitus, metabolic diseases, psychiatric, and mental disorders were excluded from the study.

Assessment of pulmonary functions {#sec2-3}
---------------------------------

Vital capacity (VC%) in inspiration (VC IN), VC in expiration (VC EX), forced expiratory volume (FEV1), forced VC (FVC), forced expiratory flow FVC, Peak expiratory flow rate PEFR and mean voluntary ventilation (MVV), and ratio of FEV1 to FVC (FEV1/FVC) were estimated by spirometry (spy-ROM-uh-tree, USA). All predicted values of the spirometric parameters were based on the patient\'s height, age, and sex. The percentage of predicted values were used for comparison of the results (% predicted = measured ÷ predicted)\[[@ref10]\]

Statistical analysis {#sec2-4}
--------------------

Data presented as mean ± standard deviation and unpaired Student\'s t-test was used to determine the significance of differences. Data analysis was done using SPSS (IBM SPSS Statistics for Windows version 20.0, 2014, IBM, Corp., Armonk, NY, USA). *P* \< 0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

The present study showed that VC EX%, FEV1%, FVC%, PEF%, and MVV%, were low in patients CSS compared with the control groups *P* \< 0.001, *P* \< 0.001, *P* \< 0.001, *P* = 0.042, and *P* = 0.037, respectively. While, there were no significant differences that had been identified between patients and controls regarding age, weight, height, BMI, VC IN%, and FEV1/FVC%, [Table 1](#T1){ref-type="table"}.

###### 

Comparison of data between all patients and all controls by unpaired *t*-test

  Parameter       Mean±SD       *P*            
  --------------- ------------- -------------- ---------
  Age (years)     50.05±12.5    49.92±11.04    0.955
  Weight (kg)     67.05±8.04    70.42±9.36     0.066
  Height (cm)     159.93±8.99   162.28±9.49    0.217
  BMI (kg/m^2^)   26.21±2.29    26.71±2.29     0.282
  VC IN (%)       90.48±14.35   94.33±13.58    0.177
  VC EX (%)       79.23±11.24   90.86±11.8     \<0.001
  FEV1 (%)        89.16±15.59   105.53±14.04   \<0.001
  FVC (%)         77.26±13.1    90.56±12.69    \<0.001
  PEF (%)         85.21±14.82   93.21±21.32    0.042
  FEV1/FVC (%)    95.72±4.08    96.56±3.89     0.302
  MVV (%)         98.42±16.77   106.14±18.55   0.037

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

As well, VC EX%, FEV1%, and FVC% were low in male patients in comparison to the controls, *P* \< 0.05. Besides, there were no significant differences regarding age, BMI, VC IN%, PEF%, FEV1/FVC%, and MVV% \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparison of data between male patients and male controls by unpaired *t*-test

  Parameter       Mean±SD        *P*            
  --------------- -------------- -------------- -------
  Age (years)     55.5±12.07     52.9±11.38     0.541
  Weight (kg)     75.0±6.38      73.87±10.46    0.749
  Height (cm)     170.5±5.97     168.4±7.89     0.446
  BMI (kg/m^2^)   25.78±1.44     25.94±2.43     0.850
  VC IN (%)       84.7±14.11     89.94±12.36    0.269
  VC EX (%)       74.71±7.51     88.32±11.71    0.001
  FEV1 (%)        88.18±12.5     105.81±16.36   0.004
  FVC (%)         73.51±9.75     88.9±13.08     0.002
  PEF (%)         89.59±14.02    92.1±16.41     0.667
  FEV1\\FVC (%)   95.36±3.11     95.9±4.33      0.715
  MVV (%)         119.11±11.67   119.2±15.24    0.987

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

Moreover, VC EX%, FEV1%, and FVC% were low in female patients compared to the controls *P* \< 0.001. Whereas, there were no significant differences that had been identified between female patients and female controls regarding age, BMI, VC IN%, PEF%, FEV1/FVC%, and MVV% \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison of data between female patients and female controls by unpaired *t*-test (*n*=30)

  Parameter       Mean±SD       *P*            
  --------------- ------------- -------------- ---------
  Age (years)     48.23±12.3    46.93±10       0.655
  Weight (kg)     64.4±6.73     66.97±6.65     0.143
  Height (cm)     156.4±6.8     156.17±6.59    0.893
  BMI (kg/m^2^)   26.35±2.52    27.48±1.86     0.051
  VC IN (%)       92.4±14.14    98.73±13.49    0.082
  VC EX (%)       80.74±11.96   93.4±11.53     \<0.001
  FEV1 (%)        89.48±16.67   105.25±11.54   \<0.001
  FVC (%)         78.5±13.96    92.21±12.29    \<0.001
  PEF (%)         83.74±15.02   94.32±25.55    0.056
  FEV1\\FVC (%)   95.84±4.39    97.22±3.33     0.177
  MVV (%)         91.52±11.79   93.08±10.72    0.594

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

On the other hand, weight, height, and MVV% were low in female patients compared to male patients, P\< 0.001 \[[Table 4](#T4){ref-type="table"}\].

###### 

Comparison of data between male and female patients by unpaired *t*-test

  Parameter       Mean±SD        *P*           
  --------------- -------------- ------------- ---------
  Age (years)     55.5±12.07     48.23±12.3    0.112
  Weight (kg)     75.0±6.38      64.4±6.73     \<0.001
  Height (cm)     170.5±5.97     156.4±6.8     \<0.001
  BMI (kg/m^2^)   25.78±1.44     26.35±2.52    0.507
  VC IN (%)       84.7±14.11     92.4±14.14    0.144
  VC EX (%)       74.71±7.51     80.74±11.96   0.144
  FEV1 (%)        88.18±12.5     89.48±16.67   0.823
  FVC (%)         73.51±9.75     78.5±13.96    0.303
  PEF (%)         89.59±14.02    83.74±15.02   0.286
  FEV1\\FVC (%)   95.36±3.11     95.84±4.39    0.747
  MVV (%)         119.11±11.67   91.52±11.79   \<0.001

SD: Standard deviation, BMI: Body mass index, VC IN: Vital capacity inspiration, VC EX: Vital capacity in expiration, FEV1: Forced expiratory volume, FVC: Forced vital capacity, PEF: Peak expiratory flow, MVV: Mean voluntary ventilation

DISCUSSION {#sec1-4}
==========

The present study illustrated insignificant differences in the anthropometric variables in patients with CSS compared to the control as revealed by Toyoda *et al*.\[[@ref11]\] Besides, the findings of the present study showed that VC%, FVC%, PEF%, FEV1%, and MVV% of patients with CSS were low compared to the controls. It has been reported that dysfunctional breathing is the main cause of morbidity and mortality after traumatic injury of the cervical spinal cord and often necessitates assisted ventilation, thus stressing the need to develop strategies to restore breathing. Cervical interneurons that form synapses on phrenic motor neurons, which control the main inspiratory muscle, can modulate phrenic motor output and diaphragmatic function.\[[@ref12]\] Therefore, patients with compressive CSS lead to the impairment of respiratory function.\[[@ref13]\] Indeed, CSS leads to weakness of diaphragm and intercostal muscles due to partial injury to the phrenic nerve and cervical nerves, respectively, as well as noteworthy reduction of sympathetic neurons activity.\[[@ref14]\] The extent of respiratory complications depends on the level of spinal stenosis, and the degree of motor impairment as VC and forced expired volume (FEV1) were normal in patients with low-level paraplegia.\[[@ref15]\] In the present study, there was no significant difference between FEV1/FVC% of patients with CSS which might due to subclinical myelopathy in the affect patients since; Aljuboori and Boakya confirmed that only advanced CSS leads to autonomic and respiratory dysfunctions.\[[@ref16]\] On the other hand, MVV% was significantly low in females in comparison to males\' patients. This is in accordance with the study done by Budhiraja *et al*.; this can be attributed to the fact that the men have bigger lungs for the same height as compared to females. Another contributing factor could be the greater strength of respiratory muscles in males.\[[@ref17]\]

Furthermore, this study confirmed that FEV1% was high specific and sensitive among other parameters of spirometry in patients with CSS since; the classification of the severity of obstructive and restrictive pulmonary impairments based on the grade of reduction in FEV1.\[[@ref18]\] Otherwise, the categorizing of restrictive impairment stated by the European Respiratory Society in 2005 has been established based on predicted FEV1%.\[[@ref19]\]

Therefore, various recommendations are reported about the management of respiratory complications associated with CSS. They include positioning and postural changes, breathing techniques, spontaneous cough and cough assistance, suctioning, respiratory muscle training, ventilation techniques and education, vaccination agents for influenza and pneumococcal infections, and pharmacological interventions. Furthermore, the modifiable risk factors must be addressed, particularly in patients with acute but not in CSS.\[[@ref20]\]

CONCLUSION {#sec1-5}
==========

Chronic CSS leads to subclinical pulmonary dysfunction due to the involvement of the phrenic nerve. FEV% is the most sensitive parameter in the detection of these disorders.
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